At 2:15 in 143ABC, Nikhil Jiwrajka presenting on Xist deletion in B-cells leading to SLE phenotypes. Again – come for the science, stay for the sure-to-be-killer slides.
At 2:15 in 143ABC, Nikhil Jiwrajka presenting on Xist deletion in B-cells leading to SLE phenotypes. Again – come for the science, stay for the sure-to-be-killer slides.
1:00 slot - Penn author Peter Merkel abstract 1696, comparison of MMF + MTX vs CYC with sequential AZA for Takayasu’s
1:00 slot - Penn author Peter Merkel abstract 1696, comparison of MMF + MTX vs CYC with sequential AZA for Takayasu’s
Vaccines in AIRDs time - Alexis Ogdie and Michael George presenting abstract 0844 on efficacy and safety of Shingrix in patients with SLE or MS
Vaccines in AIRDs time - Alexis Ogdie and Michael George presenting abstract 0844 on efficacy and safety of Shingrix in patients with SLE or MS
Presenting at 1PM: Dr. Nikhil Jiwrajka presenting abstract 0782 identifying sex differences in circulating immune landscape in scleroderma. Come for the science, stay for Dr. Jiwrajka’s masterful powerpoint skills!
Presenting at 1PM: Dr. Nikhil Jiwrajka presenting abstract 0782 identifying sex differences in circulating immune landscape in scleroderma. Come for the science, stay for Dr. Jiwrajka’s masterful powerpoint skills!
- Efficacy and safety of Upadacitinib in GCA
- With Penn's own Shubhasree Banerjee and Rennie Rhee - TAPIR trial of continuing vs stopping low dose steroids in GPA. #ACR24 @pennmedcso.bsky.social
- Efficacy and safety of Upadacitinib in GCA
- With Penn's own Shubhasree Banerjee and Rennie Rhee - TAPIR trial of continuing vs stopping low dose steroids in GPA. #ACR24 @pennmedcso.bsky.social